Giovanni Carlo Anselmetti MD, Presenter: Nothing to Disclose

Filippo Russo MD, Abstract Co-Author: Nothing to Disclose

Stefano Cirillo MD, Abstract Co-Author: Nothing to Disclose

Laura Martincich MD, Abstract Co-Author: Nothing to Disclose

Stefano DeBernardi MD, Abstract Co-Author: Nothing to Disclose

Daniele Regge Dr., Abstract Co-Author: Nothing to Disclose

To assess if percutaneous osteoplasty is effective in reducing pain and in consolidating bone in patients with painful bone metastases

19 patients suffering from painful bone metastases (14 males and 5 females, mean age 70 years) underwent percutaneous osteoplasty with polymethylmetacrilate under CT or fluoroscopic guidance. Lesions were located in femur (4 patients), tibia (2 patients), scapula (2 patients), rib (1 patient), omerus (1 patient), sacrum and hip (9 patients). Treatment were performed during local anesthesia or conscious sedation by means of 10 or 15 Gauges vertebroplasty needle. Pain was evaluated using a visual analogic scale.

All the patients reported a significant pain reduction within 24 to 72 hours from the treatment. Two patients, suffering from metastasis in the diaphisis of the femur, developed a fracture after one month (kidney cancer metastasis) and after 15 days (lung cancer metastasis) from percutaneous osteoplasty.The remaining patients had significant pain remission during a follow-up from 24 to 2 months.

Percutaneous osteoplasty is a safe and effective treament to reduce pain in patients with bone painful metasteses. A long-term bone consolidation can be achieved in most cases whereas a fracture can be observed in the lesions located in the diaphisis of the femur.

Anselmetti, G, Russo, F, Cirillo, S, Martincich, L, DeBernardi, S, Regge, D, Percutaneous Osteoplasty in Painful Bone Metastases: Technique, Result, and Complications.  Radiological Society of North America 2004 Scientific Assembly and Annual Meeting, November 28 - December 3, 2004 ,Chicago IL. http://archive.rsna.org/2004/4405770.html